Viewing StudyNCT05360680



Ignite Creation Date: 2024-05-06 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 2:31 PM
Study NCT ID: NCT05360680
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-10
First Post: 2022-04-19

Brief Title: A Phase 1 in Patients With HLA-A0201 and WT1 RecurrentMetastatic Cancers
Sponsor:
Organization: Cue Biopharma

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 52
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: